All
EHR dermatology certification may not sway physicians to buy systems
October 1st 2010New dermatology criteria from the Certification Commission for Health Information Technology (CCHIT) can simplify electronic health record (EHR) purchasing decisions, sources say. But, so far, these criteria are driving few dermatologists to implement EHRs who weren't already planning to do so, these experts add.
Dermatologists must teach younger physicians importance of giving back
October 1st 2010Many changes have occurred in dermatology over the past year in terms of educational funding. New rules have placed restrictions on how industry can financially support programs. In addition to new rules, reduced discretionary industry monies are available.
Hair loss during menopause treatable with right diagnosis
October 1st 2010Dermatologists today have more options for treating hair loss during menopause than ever before. But according to one expert in the field of female hair loss, unless the right diagnosis is made, the treatments might be less than effective.
Compression tip technology allows lasers to reach deeper tissue depths
October 1st 2010Results from ex vivo and in vivo studies combined with clinical outcomes indicate that new compression tip technology (XD Optic, Palomar Medical) is fulfilling its design objectives of safely enabling nonablative fractional treatment to increased tissue depth, according to research presented by Christine Dierickx, M.D., at the 31st annual meeting of the American Society for Laser Medicine and Surgery.
Skin substitute presents therapeutic option for venous leg ulcers
October 1st 2010Regardless of etiology, lower-extremity ulcers can be very challenging to treat, and patients may sometimes require more than the body's own natural healing abilities to close them. Dermagraft (Advanced BioHealing) is a bioengineered skin substitute that helps achieve rapid closure of lower-extremity ulcers and, according to one expert, surpasses similar products on the market.
Veteran dermatologist strives to promote skin cancer awareness
October 1st 2010Roger I. Ceilley, M.D., has had many milestones in his 33 years in dermatology. As a clinician, teacher and advocate, he has impacted not only the lives of his patients, but also the public, students, fellow dermatologists and the dermatology profession as a whole.
Amelanotic melanoma papule defies dermoscopy, reflectance confocal microscopy
October 1st 2010A case of amelanotic melanoma that upon evaluation with dermoscopy and reflectance confocal microscopy (RCM) appeared to be basal cell carcinoma (BCC) turned out to be invasive melanoma, says a dermatologist who worked on the case.
Newest diode-pumped thulium laser effective in anti-aging, aesthetic arena
October 1st 2010With the introduction of the diode pumped fiber lasers in the last decade, new laser wavelengths are now hitting the market. Introduced last year, the newest of the fiber lasers is the diode-pumped thulium laser, which emits a wavelength of 1,927 nm (Fraxel re:store, Solta Medical).
Pediatric capillary malformations respond to pulsed dye laser therapy
October 1st 2010The pulsed dye laser (PDL) can treat capillary malformations in children and, in exceptional circumstances, infantile hemangiomas, according to a professor of dermatology and pediatrics at the Medical College of Wisconsin, Milwaukee.
Physicians have limited recourse against online defamation
October 1st 2010Dr. Derm spends 10 percent of his annual gross earnings on marketing, much of which is Internet-based. He often finds himself telling his peers how wonderful Internet marketing is, until one day he finds out that a disgruntled patient has damaged his reputation on the Web. Dr. Derm is concerned that this malicious act may ruin his career. What can he do?
Dermatologists must become familiar with nail surgery techniques, expert says
October 1st 2010When faced with a potentially serious nail abnormality, some providers who take a wait-and-see approach may delay diagnosis and treatment because they aren't comfortable performing nail surgery, according to Nathaniel J. Jellinek, M.D., clinical assistant professor, department of dermatology, Brown Medical School, Providence, R.I., and adjunct clinical assistant professor, division of dermatology, University of Massachusetts Medical School, Worcester, Mass.
Dermatologists' experiences with tattoo removal procedures are varied
October 1st 2010On Call wondered whether dermatologists are seeing many complications from tattoos, or whether tattoo parlors are taking safety precautions to protect their clients. On Call also asked dermatologists whether they encounter "tattoo regret," and how they advise patients who want to have tattoos removed.
Allergan to pay $600 million to settle off-label marketing charges
October 1st 2010Allergan's recently announced $600 million settlement to resolve federal charges that it marketed Botox (onabotulinumtoxinA) for unapproved uses could hinder innovation and hamper patient care, some dermatologists worry. But in the long term, sources agree that the settlement will have little impact on the fortunes of the drug or its maker.
First staging system for cutaneous squamous cell carcinoma approved
October 1st 2010Although not as common as basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC) can metastasize and exhibit more aggressive growth patterns than BCC. As a result, many experts have called for an improved staging system for cSCC to determine prognosis of tumors.
Fillers with lidocaine among latest injectable advancements
October 1st 2010The U.S. injectable market has added lidocaine-containing versions of popular hyaluronic acid (HA) fillers, and additional fillers are expected, an expert says. Juv?derm XC (HA, lidocaine; Allergan) was available in Europe for about a year before earning Food and Drug Administration (FDA) clearance in February 2010. Restylane-L and Perlane-L (HA, lidocaine; Medicis) also won FDA approval in February 2010.
Human embryonic fibroblast stem cells improve photodamaged skin
October 1st 2010Growth factors that are developed via human fibroblast stem cells hold the promise of skin rejuvenation without presenting risks of toxicity or infection, according to an assistant professor of clinical medicine and dermatology at the University of Washington School of Medicine, Seattle.
Avoid common mistakes when planning for next year's new tax laws
October 1st 2010Changes in tax laws can catch successful people off guard. With most physicians so busy worrying about potential reimbursement reductions, they don't have the time to address the important challenge of establishing a tax-wise estate plan for their families.
Associations split on congressional move to clarify medical professionals' training
October 1st 2010There is a battle brewing in Washington by men and women who wear white coats to work. It's a battle over the manner in which non-physicians, such as nurses and nurse practitioners, can market or promote their level of service and expertise, and it has resulted in legislation being introduced in the U. S. House of Representatives.
Nano-engineering represents promising approach for vaccine delivery
October 1st 2010Nano-engineering represents a promising approach for vaccine delivery, an expert says. Immunonano-engineering capitalizes on the properties of matter on the nanoscale to design products that deliver drugs or prevent bacteria growth, or to generate new classes of drugs, says Adnan Nasir, M.D., clinical assistant professor of dermatology, University of North Carolina, Chapel Hill, N.C.
Onychomycosis in children difficult to treat without proper diagnosis
October 1st 2010Pediatric onychomycosis is relatively uncommon, with an overall prevalence among all patients with onychomycosis of about 2.5 percent. The condition occurs more often in adolescents than in young children, says Amy Paller, M.D., Walter J. Hamlin Professor, chairwoman of dermatology, professor of pediatrics, Northwestern University Feinberg School of Medicine, Chicago.
Electronic health record rules pose problems for some dermatologists
October 1st 2010The adoption of electronic health records (EHRs) among dermatologists is hitting a stumbling block - namely, the onerousness of final "meaningful use" rules recently released by the federal government. The Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) recently released guidelines for earning government incentives for implementing the paperless systems.
Financial management skills should be taught early in life
October 1st 2010Money and our ability to manage it determines how well we live, how well we are able to care for our families, how well we sleep at night, and, yes, how well we will enjoy our golden years. So why, after dealing with the stuff every day of our lives since early childhood, are so many of us klutzes in the way we handle it?
Pigmented bands in nails warrant biopsy to rule out melanoma
October 1st 2010A longitudinal pigmented band in the nail, also call longitudinal melanonychia (LM), is often a diagnostic dilemma for dermatologists. The potential causes of LM are many, but its potential signal for melanoma warrants efforts to seek a precise diagnosis.
High-dose capsaicin patch reduces postherpetic neuralgia
October 1st 2010A single, one hour-long application of a high-dose capsaicin patch recently approved by the Food and Drug Administration (FDA) not only proves to significantly reduce pain in patients suffering from postherpetic neuralgia, but also maintains its analgesic effect for up to three months.
Hypnosis can improve patients' pain experience
October 1st 2010The pain patients perceive during and after dermatologic or cosmetic procedures can sometimes be difficult to manage. Hypnosis is one technique that can significantly calm patients before and during surgery, as well as substantially reduce - and possibly even eliminate - perioperative pain.
Stash cash carefully to yield significant investment income
October 1st 2010If you depend on some of your investment portfolio to produce income, you’re suffering from a bad case of sticker shock. Let’s see what an investor with the tidy sum of $100,000 to invest might get for his money at today’s anemic interest rates.